Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson disease.

Source:http://linkedlifedata.com/resource/pubmed/id/17335306

Download in:

View as

General Info

PMID
17335306